ArticleNature communications2021

Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission.

Michele Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.